Common Contracts

2 similar License Agreement contracts

Licensing agreement for Captisol-enabled intravenous formulation of clopidogrel
License Agreement • January 28th, 2022 • New Jersey

Ligand has licensed exclusive worldwide rights to The Medicines Company for Ligand’s Captisol-enabled intravenous formulation of clopidogrel.

AutoNDA by SimpleDocs
Licensing agreement for Captisol-enabled intravenous formulation of clopidogrel
License Agreement • January 28th, 2022 • New Jersey

Ligand has licensed exclusive worldwide rights to The Medicines Company for Ligand’s Captisol-enabled intravenous formulation of clopidogrel.

Time is Money Join Law Insider Premium to draft better contracts faster.